ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
This Quarter Return
+12.26%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$199M
AUM Growth
+$199M
(+15%)
Cap. Flow
+$26.5M
Cap. Flow
% of AUM
13.33%
Top 10 Holdings %
Top 10 Hldgs %
56.26%
Holding
73
New
28
Increased
16
Reduced
8
Closed
5
Top Buys
| 1 |
Iovance Biotherapeutics
IOVA
|
$5.93M |
| 2 |
IRIDEX
IRIX
|
$5.24M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$4.98M |
| 4 |
DERM
Dermira, Inc.
DERM
|
$4.97M |
| 5 |
MDVN
MEDIVATION, INC.
MDVN
|
$3.02M |
Top Sells
| 1 |
CYNA
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
|
$7.96M |
| 2 |
Amicus Therapeutics
FOLD
|
$7.31M |
| 3 |
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
|
$5.52M |
| 4 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
$4.51M |
| 5 |
Universal Display
OLED
|
$3.73M |
Sector Composition
| 1 | Healthcare | 76.8% |
| 2 | Technology | 1.76% |
| 3 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Pacific Biosciences
PACB
$393M
| $2.11M | 1.01% | 300,000 +134,632 | +81% | +$947K |
|
|
AGN
27
DELISTED
Allergan plc
AGN
| $1.96M | 0.94% | +8,500 | New | +$1.96M |
|
|
CYNA
28
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| $1.93M | 0.93% | 115,400 -475,130 | -80% | -$7.96M |
|
29
Neurocrine Biosciences
NBIX
$13.8B
| $1.91M | 0.92% | +42,000 | New | +$1.91M |
|
|
PGNX
30
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $1.89M | 0.91% | 448,885 +216,085 | +93% | +$912K |
|
31
Travere Therapeutics
TVTX
$1.56B
| $1.76M | 0.85% | 98,788 -101,212 | -51% | -$1.8M |
|
32
ESSA Pharma
EPIX
$11.4M
| $1.75M | 0.84% | 570,232 +102,899 | +22% | +$317K |
|
33
Rigel Pharmaceuticals
RIGL
$697M
| $1.67M | 0.8% | 747,748 -29,094 | -4% | -$64.9K |
|
34
AtriCure
ATRC
$1.84B
| $1.6M | 0.77% | +112,923 | New | +$1.6M |
|
|
WBMD
35
DELISTED
WebMD Health Corp.
WBMD
| $1.45M | 0.7% | +25,000 | New | +$1.45M |
|
36
Cytokinetics
CYTK
$4.23B
| $1.34M | 0.64% | +140,969 | New | +$1.34M |
|
|
GHDX
37
DELISTED
Genomic Health, Inc.
GHDX
| $1.26M | 0.61% | +48,800 | New | +$1.26M |
|
38
Assembly Biosciences
ASMB
$190M
| $1.25M | 0.6% | +225,444 | New | +$1.25M |
|
|
RXDX
39
DELISTED
Ignyta, Inc.
RXDX
| $1.25M | 0.6% | +229,748 | New | +$1.25M |
|
|
ALIM
40
DELISTED
Alimera Sciences, Inc.
ALIM
| $1.2M | 0.58% | 974,318 | – | – |
|
|
41
Universal Display
OLED
$6.59B
| $1.02M | 0.49% | 15,000 -55,000 | -79% | -$3.73M |
|
|
RPTP
42
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| $938K | 0.45% | +174,708 | New | +$938K |
|
43
Outlook Therapeutics
OTLK
$37.8M
| $828K | 0.4% | +243,391 | New | +$828K |
|
|
SVA
44
DELISTED
Sinovac Biotech, Ltd
SVA
| $786K | 0.38% | +132,503 | New | +$786K |
|
|
MRTX
45
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $683K | 0.33% | 125,000 +21,717 | +21% | +$119K |
|
46
Ironwood Pharmaceuticals
IRWD
$214M
| $654K | 0.31% | +50,000 | New | +$654K |
|
|
BEAT
47
DELISTED
BioTelemetry, Inc.
BEAT
| $564K | 0.27% | +34,630 | New | +$564K |
|
|
AKTX
48
Akari Therapeutics
AKTX
$24.8M
| $446K | 0.21% | 33,077 +14,827 | +81% | +$200K |
|
49
CareDx
CDNA
$727M
| $279K | 0.13% | +64,627 | New | +$279K |
|
|
DXTR
50
DELISTED
Dextera Surgical Inc.
DXTR
| $232K | 0.11% | +128,958 | New | +$232K |
|